ChristopherTateSibleyMD
Cardiology • Palo Alto, CAGlobal Clinical Development Lead - TransCon PTH (palopegteriperatide) Senior Medical Director Ascendis Pharma Inc
Dr. Sibley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1000 Page Mill Road
Palo Alto, CA 94301- Is this information wrong?
Summary
- Late stage drug development with broad clinical trial experience in academics, the public sector and biopharma
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2005 - 2009
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2001 - 2005- Northwestern University The Feinberg School of MedicineClass of 2001
Certifications & Licensure
OR State Medical License 2013 - 2019
MD State Medical License Active through 2013
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism Start of enrollment: 2019 Aug 27
- A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism Start of enrollment: 2021 Feb 16
- High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsCoronary CT Angiography and Carotid MRI Improve Phenotyping of Disease Extent Compared with ACC/AHA Risk Score Alone.Ashley Chorath, Younhee Choi, Evrim B. Turkbey, Mark A. Ahlman, Christopher T. Sibley, Songtao Liu, David A. Bluemke, Veit Sandfort> ;Radiology. Cardiothoracic Imaging. 2020 Feb 27
- 224 citationsMetabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskMorgana Mongraw-Chaffin, Meredith C. Foster, Cheryl A.M. Anderson, Gregory L. Burke, Nowreen Haq, Rita R. Kalyani, Pamela Ouyang, Christopher T. Sibley, Russell P. Tra...> ;Journal of the American College of Cardiology. 2018 May 1
- 1 citationsMyocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium.Marcelo Souto Nacif, Fabio Raman, Neville Gai, Jacquin Jones, Rob J. van der Geest, Christopher T. Sibley, Songtao Liu, David A. Bluemke> ;Radiologia Brasileira. 2018 Jan 1
- Join now to see all
Authored Content
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
- Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular RiskNovember 2017
Research History
- Staff Clinician, NIHNIH Clinical Center, Nation Institute of Biomedical Imaging and Bioengineering2009 - 2013
Professional Memberships
- Member
Industry Relationships
- Medical Director, Clinical Development, Ascendis Pharma N/ATransCon PTH development program2020 - Present
- Principal Consultant, Great Point Health2017 - 2020
- Clinical Director, Merck & Co.2016 - 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
